PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

An Intrepid Solution for Transfemoral Treatment of Mitral Regurgitation.

A 5-part roundtable discussion with experts.

Margaret McEntegart discusses with Ziad Ali the genesis for his recent eccentric publication as well as Ali andDarshan Doshi’s experience with the new Shockwave C2+ catheter and how they manage the 120 pulses across lesions with heterogeneous calcium that includes concentric, eccentric and nodular calcium.